https://allsci.com/news/debt-financing/intellia-debt-facility-funding-secures-usd-400m/ AllScien 2026-09-04T17:07:54.286470Z Intellia secures USD 400m non-dilutive debt facility ahead of lonvo-z commercial launch https://allsci.com/news/regulatory/ace723-fda-clearance-hepatocellular-carcinoma/ AllScien 2026-09-04T16:30:51.466151Z Acepodia wins FDA clearance for dual-payload GPC3 ADC in liver cancer https://allsci.com/news/venture-financing/neushen-therapeutics-funding-raises-usd-80m-to/ AllScien 2026-09-04T16:21:52.761922Z NeuShen lands USD 80m+ Series B for CNS expansion https://allsci.com/news/clinical-trials/sirna-therapy-hae-argos-cuts-attack-rates-8396-in/ AllScien 2026-09-04T16:06:54.052319Z Argo's siRNA therapy cuts HAE attack rates 83–96% in small Phase II study https://allsci.com/news/clinical-trials/zorevunersen-dravet-syndrome-sustains-seizure/ AllScien 2026-09-04T15:41:17.992673Z Stoke, Biogen report four-year durability for Dravet therapy zorevunersen https://allsci.com/news/clinical-trials/oral-glp-1-agonist-innovent-launches-phase-trial/ AllScien 2026-09-04T15:40:16.839441Z Innovent takes once-weekly oral GLP-1 into Phase I https://allsci.com/news/debt-financing/dimerix-funding-kidney-disease-trial-secures-aud/ AllScien 2026-09-04T13:56:20.443867Z Dimerix secures AUD 34m non-dilutive funding through Phase III kidney disease trial readout https://allsci.com/news/regulatory-pathways/botanical-drug-development-fda-requests-public/ AllScien 2026-09-04T13:32:53.007192Z FDA requests public input on botanical drug product development pathways https://allsci.com/news/venture-financing/rare-obesity-drug-funding-superluminal-raises-usd/ AllScien 2026-09-04T13:22:17.494679Z Superluminal raises USD 60m Series B to take rare obesity drug into Phase I https://allsci.com/news/research/nitric-oxide-activated-proteins-peking-university/ AllScien 2026-09-04T12:45:18.157743Z Peking University engineers proteins that switch on in nitric oxide-rich tissues https://allsci.com/news/funding/inna-051-nasal-spray-asthma-ena-respiratory/ AllScien 2026-09-04T10:15:10.963220Z ENA expands antiviral nasal spray INNA-051 into asthma patients with grant backing https://allsci.com/news/clinical-trials/fshd-clinical-trial-antibody-sirna-souffles/ AllScien 2026-09-04T10:09:34.774413Z Soufflé joins DUX4 race in FSHD with muscle-targeted siRNA conjugate https://allsci.com/news/approvals/etripamil-china-approval-psvt-milestones-wins/ AllScien 2026-09-04T08:45:37.571434Z China approves Milestone/Everest's Cardamyst nasal spray for acute PSVT https://allsci.com/news/approvals/zanvastro-fda-approval-alexander-disease/ AllScien 2026-09-04T08:41:25.564131Z FDA approves Zanvastro as first disease-modifying treatment for Alexander disease https://allsci.com/news/licensing-and-partnerships/pembrolizumab-biosimilar-us-cipla-secures/ AllScien 2026-09-04T08:37:53.855304Z Cipla joins Keytruda biosimilar race with Qilu deal https://allsci.com/news/licensing-and-partnerships/sgk1-inhibitors-neurodegeneration-thryv-expands/ AllScien 2026-09-04T08:31:27.491090Z Thryv expands SGK1 platform into neurodegeneration with Spanish academic license https://allsci.com/news/pharma/abbvie-apogee-acquisition-acquires-for-usd-109b/ AllScien 2026-09-04T08:26:29.316937Z AbbVie closes USD 10.9b Apogee purchase for IL-13 zumilokibart https://allsci.com/news/licensing-and-partnerships/medicus-pfizer-adc-license-deal-licenses/ AllScien 2026-09-04T08:17:56.751505Z Pfizer hands former Seagen ADC to Medicus in USD 1b-plus deal https://allsci.com/news/approvals/rsv-prophylaxis-china-approval-simcere-secures/ AllScien 2026-09-04T06:57:04.809733Z China approves two homegrown long-acting RSV antibodies for infants